- Home
- HONE vs PRTC Comparison
HONE vs PRTC Comparison
Compare HONE & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HONE
- PRTC
- Stock Information
- Founded
- HONE 1917
- PRTC 2015
- Country
- HONE United States
- PRTC United States
- Employees
- HONE N/A
- PRTC N/A
- Industry
- HONE Major Banks
- PRTC Biotechnology: Pharmaceutical Preparations
- Sector
- HONE Finance
- PRTC Health Care
- Exchange
- HONE Nasdaq
- PRTC Nasdaq
- Market Cap
- HONE 525.1M
- PRTC 457.3M
- IPO Year
- HONE 2016
- PRTC N/A
- Fundamental
- Price
- HONE $11.46
- PRTC $18.47
- Analyst Decision
- HONE Hold
- PRTC Buy
- Analyst Count
- HONE 1
- PRTC 1
- Target Price
- HONE $13.00
- PRTC $45.00
- AVG Volume (30 Days)
- HONE 248.1K
- PRTC 1.8K
- Earning Date
- HONE 01-30-2025
- PRTC 08-28-2024
- Dividend Yield
- HONE 2.79%
- PRTC N/A
- EPS Growth
- HONE 78.38
- PRTC N/A
- EPS
- HONE 0.66
- PRTC N/A
- Revenue
- HONE $164,292,000.00
- PRTC $468,000.00
- Revenue This Year
- HONE N/A
- PRTC N/A
- Revenue Next Year
- HONE $10.47
- PRTC $160.00
- P/E Ratio
- HONE $17.36
- PRTC N/A
- Revenue Growth
- HONE 0.52
- PRTC N/A
- 52 Week Low
- HONE $9.16
- PRTC $17.00
- 52 Week High
- HONE $14.00
- PRTC $34.00
- Technical
- Relative Strength Index (RSI)
- HONE 42.54
- PRTC 46.10
- Support Level
- HONE $11.91
- PRTC $18.35
- Resistance Level
- HONE $12.30
- PRTC $18.89
- Average True Range (ATR)
- HONE 0.48
- PRTC 0.43
- MACD
- HONE -0.03
- PRTC 0.00
- Stochastic Oscillator
- HONE 49.66
- PRTC 26.62
About HONE HarborOne Bancorp Inc.
HarborOne Bancorp Inc is a bank holding company. The company is engaged in providing financial services like accepting deposits, lending loans, online and mobile banking, cash management, credit cards, money market accounts, and wealth management. The Company has two reportable segments: HarborOne Bank and HarborOne Mortgage. The bank provides financial services to individuals and businesses online and through its full-service branches located in Massachusetts and Rhode Island, one limited-service branch, and a commercial lending office in each of Boston, Massachusetts and Providence, Rhode Island.
About PRTC PureTech Health plc
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.